RSCM
Rock Springs Capital Management’s Cullinan Oncology CGEM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.03M | Buy |
668,233
+23,600
| +4% | +$178K | 0.31% | 63 |
|
|
2025
Q1 | $4.88M | Sell |
644,633
-97,481
| -13% | -$738K | 0.28% | 65 |
|
|
2024
Q4 | $9.04M | Buy |
742,114
+5,200
| +0.7% | +$63.3K | 0.34% | 65 |
|
|
2024
Q3 | $12.3M | Buy |
736,914
+78,576
| +12% | +$1.32M | 0.4% | 61 |
|
|
2024
Q2 | $11.5M | Buy |
+658,338
| New | +$11.5M | 0.35% | 68 |
|
|
2022
Q2 | – | Sell |
-652,578
| Closed | -$6.83M | – | 134 |
|
|
2022
Q1 | $6.83M | Buy |
652,578
+6,500
| +1% | +$68.1K | 0.17% | 95 |
|
|
2021
Q4 | $9.97M | Sell |
646,078
-429,834
| -40% | -$6.63M | 0.23% | 90 |
|
|
2021
Q3 | $24.3M | Hold |
1,075,912
| – | – | 0.51% | 64 |
|
|
2021
Q2 | $27.7M | Hold |
1,075,912
| – | – | 0.55% | 56 |
|
|
2021
Q1 | $44.8M | Buy |
+1,075,912
| New | +$44.8M | 0.98% | 32 |
|